These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4601596)

  • 41. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts.
    Gaber AO; Thistlethwaite JR; Haag BW; Stuart JK; Mayes JT; Lloyd DM; Fellner S; Stuart FP
    Am Surg; 1987 Jul; 53(7):407-9. PubMed ID: 3300451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serologically defined HL-A antigens and long-term survival of cadaver kidney transplants. A joint analysis of 918 cases performed by France-Transplant and the London Transplant Group.
    Dausset J; Hors J; Busson M; Festenstein H; Oliver RT; Paris AM; Sachs JA
    N Engl J Med; 1974 May; 290(18):979-84. PubMed ID: 4594524
    [No Abstract]   [Full Text] [Related]  

  • 43. Second kidney transplants and presensitization.
    Opelz G; Terasaki PI
    Transplant Proc; 1972 Dec; 4(4):743-8. PubMed ID: 4566824
    [No Abstract]   [Full Text] [Related]  

  • 44. Leukocyte antigens in cadaver transplantation.
    Morris PJ; Kincaid-Smith P; Marshall VC
    Transplant Proc; 1969 Mar; 1(1):376-8. PubMed ID: 4944242
    [No Abstract]   [Full Text] [Related]  

  • 45. Limitation of the lymphocyte cytotoxicity crossmatch test in recipients of kidney transplants having preformed antileukocyte antibodies.
    Patel R; Briggs WA
    N Engl J Med; 1971 May; 284(18):1016. PubMed ID: 4928657
    [No Abstract]   [Full Text] [Related]  

  • 46. False-positive crossmatch owing to autoantibodies induced by donor-specific transfusions without development of alloantibodies.
    López Blanco OA; Cavalli NH; Raimondi E; Haas EJ; Verruno L; Gotlieb D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):768-70. PubMed ID: 2650264
    [No Abstract]   [Full Text] [Related]  

  • 47. Retransplantation in children.
    Fine RN; Malekzadeh MH; Pennisi AJ; Ettenger RB; Uittenbogaart CH; Korsch BM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():78-81. PubMed ID: 386324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histocompatibility in humans.
    Fotino M
    Ann Clin Lab Sci (1971); 1971; 1(2):125-30. PubMed ID: 4405210
    [No Abstract]   [Full Text] [Related]  

  • 49. Recipient selection for renal retransplantation.
    Opelz G; Terasaki PI
    Transplantation; 1976 Jun; 21(6):483-8. PubMed ID: 779172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kidney transplantation and donor age.
    Morling N; Ladefoged J; Lange P; Nerstrom B; Nielsen B; Nielsen LS; Sorensen BL
    Tissue Antigens; 1975 Sep; 6(3):163-6. PubMed ID: 1103363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal transplantation.
    Atkins RC
    Med J Aust; 1976 Feb; 1(8):230-3. PubMed ID: 772382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kidney preservation for transportation. Function of 29 human-cadaver kidneys preserved with an intracellular perfusate.
    Hartley LC; Collins GM; Clunie GJ
    N Engl J Med; 1971 Nov; 285(19):1049-52. PubMed ID: 4937692
    [No Abstract]   [Full Text] [Related]  

  • 53. Tissue typing in human kidney transplantation: a review.
    Patel R; Mocelin A
    J Urol; 1972 May; 107(5):684-7. PubMed ID: 4553915
    [No Abstract]   [Full Text] [Related]  

  • 54. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical experiences with preservation of necrokidneys. The effect of pretreatment with chlorpromazine and the use of a perfusate which mimics the intracellular ion composition.
    Lokkegaard H; Nerstrom B
    Acta Med Scand; 1973; 1-2(1):5-11. PubMed ID: 4580323
    [No Abstract]   [Full Text] [Related]  

  • 56. Operative blood flow measurement in transplanted human kidneys and subsequent rejection.
    Bergentz SE; Brunius U; Gelin LE; Lewis DH
    Ann Surg; 1971 Jul; 174(1):44-7. PubMed ID: 4933527
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunologic problems of organ-grafting in man. II. Antigenic selection of graft donors and recipients].
    Turowski G; Skowron-Cendrzak A
    Przegl Lek; 1971; 28(7):499-502. PubMed ID: 4398404
    [No Abstract]   [Full Text] [Related]  

  • 58. Relationship of mixed lymphocyte culture response, HL-A histocompatibility antigens, and renal transplantation.
    Thompson JS; Flink RJ; Caldwell JL; Severson CD; Bonney WW
    Transplant Proc; 1973 Dec; 5(4):1763-9. PubMed ID: 4130081
    [No Abstract]   [Full Text] [Related]  

  • 59. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients.
    Davis RC; Nabseth DC; Olsson CA; Idelson BA; Schmitt GW; Cho SI; Mannick JA
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):67-70. PubMed ID: 4612906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.